<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: We examined the relationship between <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and vascular function in three insulin-resistant states (type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, non-HIV lipodystrophic <z:mp ids='MP_0002055'>diabetes</z:mp>, and nondiabetic <z:hpo ids='HP_0000147'>polycystic ovary</z:hpo> syndrome [<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCOS</z:e>]) and in healthy control subjects </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: The population included 12 women with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, 6 with lipodystrophic <z:mp ids='MP_0002055'>diabetes</z:mp>, 10 with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCOS</z:e>, and 19 healthy female subjects </plain></SENT>
<SENT sid="2" pm="."><plain>Metabolic measures included insulin sensitivity by the homeostasis model assessment, <z:chebi fb="23" ids="18059">lipids</z:chebi>, free fatty acids, and adiponectin </plain></SENT>
<SENT sid="3" pm="."><plain>High-resolution B-mode ultrasound was used to determine endothelium-dependent and -independent vasodilation </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Type 2 diabetic, liposdystrophic, and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCOS</z:e> subjects were insulin resistant compared with control subjects (P = 0.001) </plain></SENT>
<SENT sid="5" pm="."><plain>Flow-mediated vasodilation was reduced in diabetic (3.4 +/- 1.3%) compared with control (7.3 +/- 1.1%) subjects but not in lipodystrophic (7.7 +/- 1.2%) or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCOS</z:e> (9.9 +/- 0.7%) subjects (P = 0.005) </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="0" ids="28787">Nitroglycerin</z:chebi>-mediated vasodilation was attenuated in both diabetic (15.2 +/- 2.0%) and lipodystrophic (16.7 +/- 3.6%) subjects compared with healthy control (24.6 +/- 2.4%) and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCOS</z:e> (23.2 +/- 1.8%) subjects (P = 0.019) </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0000855'>Insulin resistance</z:hpo>, free fatty acids, adiponectin, or C-reactive protein did not associate with vascular dysfunction </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Among these different types of patients with <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, we found abnormal endothelium-dependent vasodilation only in the patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="9" pm="."><plain>We postulate that variations in the mechanism of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> may affect endothelial function differently than <z:chebi fb="105" ids="17234">glucose</z:chebi> homeostasis </plain></SENT>
</text></document>